Keyword Connections

hiv infections / drug therapy*

Journals

0

No Journal Connected

Research Groups

0

No Research Group Connected

Bibliographies

18

1 Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe

2 Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial

3 Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007

4 Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy

5 Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies

6 Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination

7 Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group

8 Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa

9 Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis

10 Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data

11 Effect of combination antiretroviral therapy upon rectal mucosal HIV RNA burden and mononuclear cell apoptosis

12 Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy

13 Neurodevelopmental functioning in HIV-infected infants and young children before and after the introduction of protease inhibitor-based highly active antiretroviral therapy

14 Evaluation of human immunodeficiency virus (HIV) type 1 RNA levels in cerebrospinal fluid and viral resistance to zidovudine in children with HIV encephalopathy

15 Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy

16 Exacerbation of skin mycobacterial lesions under highly active antiretroviral therapy in an HIV-infected patient

17 Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance

18 Nutritional status and mortality among HIV-infected patients receiving antiretroviral therapy in Tanzania